Prospective Multicentre Noninterventional Observational Study on Predictors of Treatment Response in a Cohort of Treatment naive HIV-infected Patients Treated With Saquinavir (PROSPECTOR).
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2013
At a glance
- Drugs Saquinavir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PROSPECTOR
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 07 Oct 2013 Planned End Date changed from 1 Sep 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
- 01 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.